← Back to Search

Behavioral Intervention

Cognitive Behavioral Therapy for Depression and Suicide Prevention

Phase 2
Recruiting
Led By Lisa A Brenner, PhD
Research Sponsored by VA Eastern Colorado Health Care System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Veterans between the ages of 18 and 65
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to investigate the effectiveness of two different online courses for improving mental health. One course focuses on treating symptoms of depression while the other focuses on addressing past suicidal thoughts and behaviors.

Who is the study for?
This trial is for individuals experiencing depression or having a history of suicidal thoughts and behaviors. Participants will engage in self-guided online cognitive behavioral therapy courses designed to address these issues.
What is being tested?
The study is testing two different self-guided online cognitive behavioral therapy (CBT) courses: one tailored for managing symptoms of depression, and the other focused on coping with suicidal thoughts and behaviors.
What are the potential side effects?
Since this trial involves non-medical interventions like CBT, traditional side effects associated with medications are not expected. However, participants may experience emotional discomfort addressing sensitive topics.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a veteran aged between 18 and 65.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Client Satisfaction Questionnaire
Completion of intervention
Internet Evaluation and Utility Questionnaire
+3 more
Secondary study objectives
Beck Scale for Suicide Ideation
Computerized Adaptive Testing - Suicide Scale
Generalized Anxiety Disorder-7
+2 more

Side effects data

From 2021 Phase 4 trial • 12 Patients • NCT04135937
8%
irritability
100%
80%
60%
40%
20%
0%
Study treatment Arm
MESH

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Cognitive Behavioral TherapyExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive Behavioral Therapy
2016
Completed Phase 4
~3120

Find a Location

Who is running the clinical trial?

VA Eastern Colorado Health Care SystemLead Sponsor
54 Previous Clinical Trials
25,746 Total Patients Enrolled
Lisa A Brenner, PhDPrincipal InvestigatorVA Eastern Colorado Health Care System
6 Previous Clinical Trials
2,132 Total Patients Enrolled
~52 spots leftby Dec 2024